Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma

Neoplasia

Volumn 7, Issue 1, 2005, Pages 1-6

  Koukourakis, Michael I ^a,c   Giatromanolaki, Alexandra ^a   Sivridis, Efthimios ^a   Gatter, Kevin C ^b   Harris, Adrian L ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c Tumor and Angiogenesis Research Group Alexandroupolis   (Greece)

Author keywords

HIF; Lung cancer; PDH; PDH kinase; Stroma

Indexed keywords

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; LACTIC ACID; PHOSPHOTRANSFERASE; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE KINASE; PYRUVIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; TUMOR VASCULARIZATION;

EID: 13444272912     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04373     Document Type: Article

References (20)

1. Harris RA, Bowker-Kinley MM, Hyang B, and Wu P (2002). Regulation of the activity of the pyruvate dehydrogenase complex. Adv Enzyme Regul 42, 2249-2259.
2. Reed LJ and Hackert ML (1990). Structure-function relationships in dihydrolipoamide acyltransferases. J Biol Chem 265, 8971-8974.
3. Sanderson SJ, Miller C, and Lindsay JG (1996). Stoichiometry, organisation and catalytic function of protein X of the pyruvate dehydrogenase complex from bovine heart. Eur J Biochem 236, 68-77.
4. Maeng CY, Yazdi MA, Niu XD, Lee HY, and Reed LJ (1994). Expression, purification, and characterization of the dihydrolipoamide dehydrogenase-binding protein of the pyruvate dehydrogenase complex from Saccharomyces cerevisiae. Biochemistry 33, 13801-13807.
5. Harris RA, Bowker-Kinley MM, Wu P, Jeng J, and Popov KM (1997). Dihydrolipoamide dehydrogenase-binding protein of the human pyruvate dehydrogenase complex. DMA-derived amino acid sequence, expression, and reconstitution of the pyruvate dehydrogenase complex. J Biol Chem 272, 19746-19751.
6. Harris RA, Huang B, and Wu P (2001). Control of pyruvate dehydrogenase kinase gene expression. Adv Enzyme Regul 41, 269-288.
7. Sugden MC and Holness MJ (2003). Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am J Physiol Endocrinol Metab 284, 855-862.
8. Holbrook JJ, Liljas A, Steindel SJ, and Rossman MG (1975). In Boyer, PD (Ed.), 3rd ed. Lactate dehydrogenase: Vol XI. The Enzymes, pp. 191-292 Academic Press, New York.
9. Warburg O (1956). On the origin of cancer cells. Science 123 (391), 309-314.
10. Semenza GL, Roth PH, Fang HM, and Wang GL (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269, 23757-23763.
11. Lu H, Forbes RA, and Verma A (2002). Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277, 23111-23115.
12. Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC, and Harris AL (2001). Relation of hypoxia-inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 85, 881-890.
13. Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter KC, and Harris AL (2001). Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 61, 7992-7998.
14. Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL.Tumour and Angiogenesis Research Group (2003). Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer 89, 877-885.
15. Giatromanolaki A, Koukourakis M, O'Byrne K, Fox S, Whitehouse R, Talbot D, Harris AL, and Garter KC (1996). Prognostic value of angiogenesis in operable non-small cell lung cancer. J Parthol 179, 80-88.
16. Koukourakis MI, Giatromanolaki A, and Sivridis E (2003). Lactate dehydrogenase (LDH) isoenzymes 1 and 5 expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors. Tumor Biol 24, 199-202.
17. Eboli ML and Pasquini A (1994). Transformation linked decrease of pyruvate dehydrogenase complex in human epidermis. Cancer Lett 85, 239-243.
18. Eboli ML (1985). Pyruvate dehydrogenase levels in Morris hepatomas with different growth rate. Cancer Lett 26, 185-190.
19. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, and Giallongo A (1996). Hypoxia response elements in the A aldolase, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271, 32529-32537.
20. Giatromanolaki A, Koukourakis MI, Sivridis E, O'Byrne K, Gatter KC, and Harris AL (2000). "Invading edge vs inner" (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer. J Pathol 192, 140-149.